Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Browman

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
Seminars in Oncology|June 1, 1987
Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemiaA Raza, Y Maheshwari, N Mandava, et al.
British Journal of Haematology|July 1, 1990
MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemiaH Sato, H Preisler, R Day, et al.
British Journal of Haematology|April 1, 1989
Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup studyG Browman, H Preisler, A Raza, et al.
American Journal of Hematology|August 1, 1993
Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: a leukemia intergroup studyJ Goldberg, J Gryn, A Raza, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: relationship to response to remission induction therapyH D Preisler, A Raza, N Azarnia, et al.
Leukemia Research|January 1, 1991
Cell cycle and clinical characteristics of patients with acute myeloid leukemia and myelodysplasia whose biopsies are reactive with anti-factor VIII antibody. A Leukemia Intergroup StudyS P Khan, A Raza, M Barcos, et al.
Blood|January 1, 1989
Protooncogene expression and the clinical characteristics of acute nonlymphocytic leukemia: A Leukemia Intergroup pilot studyH D Preisler, A Raza, R Larson, et al.
Gynecologic Oncology|May 15, 2007
Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guidelineL Elit, L Zitzelsberger, M Fung-Kee-Fung, et al.
American Journal of Hematology|October 1, 1986
High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup studyH D Preisler, A Raza, M Barcos, et al.
Blood|December 1, 1990
Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup studyA Raza, H D Preisler, R Day, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Seminars in Oncology|June 1, 1987
Cell cycle and drug sensitivity studies of leukemic cells that appear relevant in determining response to chemotherapy in acute nonlymphocytic leukemiaA Raza, Y Maheshwari, N Mandava, et al.
British Journal of Haematology|July 1, 1990
MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemiaH Sato, H Preisler, R Day, et al.
British Journal of Haematology|April 1, 1989
Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup studyG Browman, H Preisler, A Raza, et al.
American Journal of Hematology|August 1, 1993
Mitoxantrone and 5-azacytidine for refractory/relapsed ANLL or CML in blast crisis: a leukemia intergroup studyJ Goldberg, J Gryn, A Raza, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1985
Changes in the characteristics of the bone marrow during therapy for acute non-lymphocytic leukemia: relationship to response to remission induction therapyH D Preisler, A Raza, N Azarnia, et al.
Leukemia Research|January 1, 1991
Cell cycle and clinical characteristics of patients with acute myeloid leukemia and myelodysplasia whose biopsies are reactive with anti-factor VIII antibody. A Leukemia Intergroup StudyS P Khan, A Raza, M Barcos, et al.
Blood|January 1, 1989
Protooncogene expression and the clinical characteristics of acute nonlymphocytic leukemia: A Leukemia Intergroup pilot studyH D Preisler, A Raza, R Larson, et al.
Gynecologic Oncology|May 15, 2007
Use of systemic therapy in women with recurrent ovarian cancer--development of a national clinical practice guidelineL Elit, L Zitzelsberger, M Fung-Kee-Fung, et al.
American Journal of Hematology|October 1, 1986
High-dose cytosine arabinoside in the treatment of preleukemic disorders: a leukemia intergroup studyH D Preisler, A Raza, M Barcos, et al.
Blood|December 1, 1990
Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup studyA Raza, H D Preisler, R Day, et al.
Pageof 6